| Phase 3 |
| NCT06930625 |
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly… |
Acromegaly |
Recruiting |
2026-09-22 |
| NCT06129539 |
A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric… |
Central Precocious Puberty |
Active, Not Recruiting |
2026-09-22 |
| Phase 1/2 |
| NCT05765812 |
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With… |
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype |
Recruiting |
2026-09-22 |
| NCT06969430 |
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in… |
Acute Myeloid Leukemia |
Recruiting |
2026-09-11 |
| Phase 1 |
| NCT04855656 |
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With… |
Advanced Solid Tumor |
Recruiting |
2026-09-22 |
| NCT07035769 |
A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single… |
Healthy Participants |
Recruiting |
2026-09-22 |
| NCT07758608 |
Renal Impairment Pharmacokinetics (PK) Trial of Afabicin |
Renal Impairment |
Not Yet Recruiting |
2026-09-22 |